Company intelligence / Profile preview

Mustang Therapeutics

Waltham, Massachusetts, United Statesmustangbio.com ↗

Ownership: Private
Employees: ~6
Development stage: Phase 1

Overview

Mustang Bio has demonstrated early clinical success in several programs. Its gene therapy for X-SCID showed positive results in a trial involving infants. Multiple CAR-T programs are advancing through early-stage clinical trials for both hematologic and solid tumor indications. The oncolytic virus program received Orphan Drug status for malignant glioma.

Therapeutic areas: OncologyImmunology
Modalities: CAR-T cell therapiesGene therapies (lentiviral vectors)Oncolytic viruses
Industry: Biotech

Drug pipeline

3 assets

MB-109

Pre-clinical

Indications: Glioblastoma, High-grade astrocytoma

2 more assets in the full pipeline.

Request access →

Partnerships

City of Hope National Medical CenterFred Hutchinson Cancer Research CenterSt Jude Children’s Research HospitalNationwide Children’s HospitalCSL BehringMayo ClinicLeiden University Medical CentreSIRION Biotech GmbH

Beyond the preview

Go deeper on Mustang Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mustang Therapeutics.

Explore the full profile